A Single-center, Randomized Controlled Clinical Study of Selinexor Combined With BEAM as a Preconditioning Regimen for ASCT in Relapsed and Refractory Diffuse Large B-cell Lymphoma With MYC Positive
Latest Information Update: 25 Oct 2024
At a glance
- Drugs Selinexor (Primary) ; Carmustine; Cytarabine; Etoposide; Melphalan
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 25 Oct 2024 New trial record